C12N 5/0641
Erythrocytes
Official title: {Erythrocytes}
C12N5/0641 (Erythrocytes) appears on 271 US grants and 473 published applications in this corpus.
Search patents in C12N- Granted patents
- 271
- Published applications
- 473
- Assignees
- 243
- Inventors
- 770
- Latest grant
- 21 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1994 | 1 | 0 |
| 1995 | 3 | 0 |
| 1996 | 1 | 0 |
| 1997 | 8 | 0 |
| 1998 | 3 | 0 |
| 1999 | 7 | 0 |
| 2000 | 1 | 0 |
| 2001 | 5 | 1 |
| 2002 | 4 | 8 |
| 2003 | 6 | 6 |
| 2004 | 2 | 9 |
| 2005 | 3 | 12 |
| 2006 | 2 | 5 |
| 2007 | 3 | 11 |
| 2008 | 3 | 5 |
| 2009 | 6 | 4 |
| 2010 | 3 | 5 |
| 2011 | 8 | 17 |
| 2012 | 6 | 20 |
| 2013 | 9 | 14 |
| 2014 | 12 | 24 |
| 2015 | 12 | 30 |
| 2016 | 15 | 34 |
| 2017 | 15 | 18 |
| 2018 | 16 | 36 |
| 2019 | 23 | 45 |
| 2020 | 22 | 32 |
| 2021 | 11 | 22 |
| 2022 | 16 | 33 |
| 2023 | 11 | 23 |
| 2024 | 14 | 18 |
| 2025 | 13 | 19 |
| 2026 | 7 | 22 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- End-to-end cell therapy bioprocessing device for continuous-flow enrichment, washing, and electrotransfection of target cells21 Jul 2026US 12,686,843 B2The Charles Stark Draper Laboratory, Inc.
- Preparation method and application of vesicle formed by erythrocyte membrane encapsulating Newcastle disease virus30 Jun 2026US 12,668,783 B2
- Processes and systems for preparing cellular or viral membranes and nanoparticles31 Mar 2026US 12,590,189 B2Arytha Biosciences, LLC
- Blood substitutes comprising hemoglobin and methods of making24 Mar 2026US 12,582,703 B2VirTech Bio, Inc.
- Hypothermic 3D bioprinting of living tissues supported by perfusable vasculature24 Mar 2026US 12,584,103 B2William Marsh Rice University
- Process for purifying red blood cell membrane fragments8 Oct 2026US 2026/0306656 A1Ohio State Innovation Foundation
- Processes and systems for preparing cellular or viral membranes and nanoparticles8 Oct 2026US 2026/0308337 A1Arytha Biosciences, LLC
- Use of a vitisin compound for the production of hematopoietic cells10 Sep 2026US 2026/0265694 A1Etablissement Francais Du Sang
- Lysis/Binding Solution, Cleaning Solution, Kit and Method for Nucleic Acid Extraction27 Aug 2026US 2026/0250658 A1Beijing BOE Technology Development Co., Ltd.
- Methods for producing red blood cells and platelets13 Aug 2026US 2026/0234560 A1Dewcell, Inc.
Most cited
By later US patents
- Method for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells210US 5,437,994 AThe Regents of the University of Michigan · 1995
- Methods and compositions for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells159US 6,326,198 B1The Regents of the University of Michigan · 2001
- Methods, compositions and devices for maintaining and growing human stem and/or hematopoietics cells151US 5,763,266 AThe Regents of the University of Michigan · 1998
- Methods for regulating the specific lineages of cells produced in a human hematopoietic cell culture146US 5,635,386 AThe Regents of the University of Michigan · 1997
- Methods for the ex vivo replication of human stem cells and/or expansion of human progenitor cells145US 5,646,043 AThe Regents of the University of Michigan · 1997